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   ABSTRACT	  THE	  IDENTIFICATION	  OF	  NOTCH1	  FUNCTIONAL	  DOMAINS	  RESPONSIBLE	  FOR	  ITS	  PHYSICAL	  INTERACTION	  WITH	  PKCθ	  	  FEBRUARY	  2016	  WESLEY	  D.	  ROSSITER,	  B.S.,	  UNIVERSITY	  OF	  MASSACHUSETTS	  AMHERST	  M.S.,	  UNIVERSITY	  OF	  MASSACHUSETTS	  AMHERST	  Directed	  by:	  	  Professor	  Lisa	  M.	  Minter	  	  	   The	  adaptive	  immune	  system	  is	  a	  complex	  network	  of	  cells	  that	  protect	  the	  body	  from	  invasion	  by	  foreign	  pathogens.	  Crucial	  to	  the	  function	  of	  the	  adaptive	  immune	  system	  is	  the	  activation,	  proliferation	  and	  differentiation	  of	  T	  cells	  in	  response	  to	  foreign	  pathogen	  presentation	  by	  antigen	  presenting	  cells.	  T	  cell	  activation	  is	  driven	  through	  different	  signaling	  pathways	  that	  are	  dependent	  on	  phosphorylation	  of	  substrates	  by	  kinases.	  In	  the	  PLC	  pathway	  that	  activates	  the	  il2	  gene	  program,	  Protein	  Kinase	  C-­‐θ	  (PKCθ)	  and	  Notch1	  localize	  to	  the	  immunological	  synapse	  and	  help	  drive	  the	  signaling	  cascade	  that	  leads	  to	  robust	  T	  cell	  activation.	  It	  has	  been	  previously	  shown	  that	  PKCθ	  and	  Notch1,	  both	  interact	  with	  the	  CBM	  complex	  at	  the	  immunological	  synapse.	  Additionally,	  PKCθ	  and	  Notch1	  both	  have	  specific	  cytoplasmic	  and	  nuclear	  functions	  that	  help	  drive	  the	  il2	  gene	  program.	  Here,	  we	  demonstrate	  the	  localization	  of	  PKCθ	  and	  Notch1	  constructs	  transfected	  into	  HEK	  293	  cells.	  The	  use	  of	  deletion	  constructs	  of	  Notch1	  was	  intended	  to	  inform	  us	  of	  what	  functional	  domain	  of	  Notch1	  was	  responsible	  for	  the	  interaction	  with	  PKCθ,	  however	  no	  direct	  interaction	  was	  demonstrated	  with	  the	  PKCθ	  and	  Notch1	  constructs	  used	  in	  these	  experiments.	  We	  hypothesize	  that	  this	  is	  likely	  due	  to	  the	  inactive	  form	  of	  PKCθ	  found	  in	  our	  construct,	  or	  a	  result	  of	  the	  cell	  type	  used	  in	  these	  experiments.	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CHAPTER	  1	  
THE	  ROLE	  OF	  NOTCH	  AND	  PKCθ	  SIGNALING	  IN	  THE	  DEVELOPMENT,	  ACTIVATION	  AND	  
POLARIZATION	  OF	  THE	  ADAPTIVE	  IMMUNE	  RESPONSE	  	  
1.1.	  Adaptive	  Immune	  Response	  
1.1.1.	  Introduction	  	   The	  adaptive	  immune	  system	  is	  an	  extremely	  complex	  network	  of	  specific	  cells	  and	  processes	  that	  protect	  the	  body	  against	  invasion	  from	  foreign	  pathogens.	  Crucial	  to	  the	  function	  of	  the	  adaptive	  immune	  system,	  also	  called	  the	  acquired	  immune	  system,	  is	  the	  ability	  to	  maintain	  self-­‐tolerance	  while	  maintaining	  surveillance	  to	  foreign	  invaders.	  The	  adaptive	  immune	  system	  can	  be	  divided	  into	  two	  components,	  humoral	  immunity	  and	  cell-­‐mediated	  immunity.	  	  The	  key	  lymphocyte	  in	  the	  cell-­‐mediated	  component	  of	  the	  adaptive	  immune	  system	  is	  the	  T	  cell.	  	  T	  cells	  undergo	  a	  stringent	  selection	  process	  to	  produce	  a	  functional	  antigen-­‐binding	  receptor	  known	  as	  the	  T-­‐cell	  receptor	  (TCR).	  T	  cells	  expressing	  the	  TCR	  recognize	  a	  specific	  antigen	  bound	  to	  a	  membrane	  protein	  of	  an	  antigen-­‐presenting	  cell	  (APC)	  called	  major	  histocompatibility	  complex	  (MHC)	  molecules.	  	  	   The	  development	  of	  T	  cells	  begins	  in	  the	  bone	  marrow,	  where	  hemapotoietic	  stem	  cells	  (HSCs)	  continuously	  self-­‐renew	  until	  their	  differentiation	  into	  specific	  cell	  types	  is	  initiated	  through	  a	  vast	  array	  of	  signals	  that	  drive	  the	  HSCs	  towards	  a	  particular	  fate.	  In	  the	  bone	  marrow,	  several	  types	  of	  cells	  are	  responsible	  for	  directing	  HSC	  development	  including	  osteoblasts,	  endothelial	  cells,	  reticular	  cells,	  and	  sympathetic	  neurons	  (Wang	  et	  al.,	  2011).	  Micro-­‐niches	  within	  the	  bone	  marrow	  play	  an	  important	  role	  in	  HSC	  development	  by	  providing	  different	  environmental	  signals	  to	  HSCs.	  In	  the	  endosteal	  niche	  HSCs	  continuously	  self-­‐renew,	  whereas	  HSCs	  in	  the	  vascular	  niche	  begin	  to	  differentiate	  or	  circulate	  to	  other	  tissues	  (Morrison	  et	  al.,	  2008).	  T-­‐cell	  precursors	  mobilize	  from	  the	  bone	  marrow	  and	  travel	  through	  the	  circulatory	  system	  to	  the	  thymus	  where	  they	  assume	  the	  name	  thymocytes.	  Once	  inside	  the	  thymus,	  thymocytes	  begin	  to	  mature	  into	  T	  cells	  expressing	  unique	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antigen-­‐specific	  receptors,	  TCRs.	  At	  this	  stage	  in	  development	  thymocytes	  express	  both	  CD4	  and	  CD8	  receptors	  and	  are	  referred	  to	  as	  double	  positive	  T	  cells.	  Positive	  selection	  is	  the	  first	  stage	  of	  thymocyte	  development	  in	  the	  thymus	  following	  the	  generation	  of	  their	  TCRs,	  in	  which	  thymocytes	  with	  an	  intermediate	  affinity	  for	  the	  self	  MHC-­‐peptide	  complexes	  presented	  by	  thymic	  epithelial	  cells	  are	  positively	  selected.	  Thymocytes	  with	  too	  low	  an	  affinity	  for	  the	  self	  MHC-­‐peptide	  complexes	  die	  from	  neglect	  in	  the	  thymus	  (Klien	  et	  al.,	  2009).	  The	  second	  stage	  of	  selection	  ensures	  the	  TCR	  on	  developing	  thymocytes	  does	  not	  bind	  self	  MHC-­‐peptide	  complexes	  with	  too	  high	  affinity,	  in	  a	  process	  called	  negative	  selection.	  Thymocytes	  that	  react	  too	  strongly	  to	  the	  self	  MHC-­‐peptide	  complexes	  are	  induced	  to	  die,	  preventing	  immune-­‐mediated	  destruction	  of	  healthy,	  normal	  tissue.	  Mature	  thymocytes	  that	  have	  the	  appropriate	  affinity	  for	  the	  self	  MHC-­‐peptide	  complexes	  express	  either	  a	  CD4	  or	  CD8	  receptor	  and	  are	  referred	  to	  as	  single	  positive	  mature	  thymocytes.	  These	  cells	  circulate	  in	  the	  peripheral	  blood	  and	  become	  activated	  to	  expand	  and	  differentiate	  further	  following	  the	  presentation	  of	  a	  foreign	  peptide	  by	  an	  APC.	  
1.1.2	  T	  Cell	  Activation	  and	  Polarization	  	   T	  cells	  that	  have	  undergone	  selection	  in	  the	  thymus	  and	  enter	  the	  periphery	  are	  called	  naïve	  T	  cells	  until	  they	  encounter	  an	  antigen.	  Naïve	  T	  cells	  circulate	  through	  secondary	  lymphoid	  organs	  such	  as	  the	  spleen	  or	  lymph	  nodes	  until	  they	  become	  activated	  through	  the	  engagement	  of	  their	  TCR	  through	  the	  presentation	  of	  an	  antigen	  loaded	  onto	  a	  self	  MHC	  molecule	  that	  is	  recognized	  by	  the	  T	  cells’	  CD4	  or	  CD8	  receptor.	  	  Complete	  activation	  of	  T	  cells	  requires	  a	  co-­‐stimulatory	  signal	  and	  the	  presence	  of	  stimulatory	  molecules	  called	  cytokines.	  The	  CD28	  co-­‐stimulatory	  receptor	  on	  T	  cells	  is	  responsible	  for	  providing	  a	  secondary	  signal	  that	  drives	  robust	  activation	  when	  it	  binds	  the	  co-­‐stimulatory	  ligand	  CD80(B7-­‐1)/CD86(B7-­‐2)	  expressed	  on	  the	  surface	  of	  Dendritic	  cells	  (DCs)	  (Nunes	  et	  al.,	  1996).	  Following	  the	  engagement	  of	  the	  TCR	  together	  with	  co-­‐stimulatory	  signals,	  T	  cells	  initiate	  a	  signaling	  cascade	  characterized	  by	  several	  phosphorylation	  events	  and	  localization	  of	  proteins	  at	  the	  cell	  membrane	  that	  ultimately	  drive	  an	  alteration	  in	  the	  transcriptional	  program	  of	  
	   3	  
the	  cell.	  The	  phospholipase	  C	  (PLC)	  pathway	  in	  T	  cells	  activates	  the	  gene	  program	  for	  interleukin	  2(IL-­‐2),	  a	  cytokine	  that	  helps	  drive	  T	  cell	  proliferation	  (Schwartz,	  1990).	  The	  transcription	  factors	  necessary	  to	  drive	  the	  IL2	  gene	  program	  are	  activated	  protein-­‐1	  (AP-­‐1),	  nuclear	  factor	  kappa-­‐light-­‐chain-­‐enhancer	  of	  activated	  B	  cells	  (NF-­‐κB),	  and	  nuclear	  factor	  of	  activated	  T	  cells	  (NFAT).	  These	  transcription	  factors	  are	  only	  able	  to	  localize	  to	  the	  IL2	  gene	  following	  a	  signaling	  cascade	  initiated	  by	  a	  sustained	  TCR	  engagement	  and	  phosphorylation	  events	  at	  the	  immunological	  synapse.	  	  After	  24-­‐48	  hours	  following	  successful	  TCR	  engagement,	  T	  cells	  up-­‐regulate	  the	  transcription	  of	  IL2rα,	  the	  high	  affinity	  IL-­‐2	  receptor	  (CD25),	  and	  pro-­‐survival	  genes.	  	  	   The	  polarization	  of	  activated	  T	  cells	  depends	  on	  the	  signals	  received	  from	  cytokines	  present	  during	  the	  activation.	  	  T	  cells	  come	  in	  a	  variety	  of	  subsets,	  divided	  into	  two	  groups	  based	  on	  their	  recognition	  of	  MHC	  class	  I	  or	  II.	  Cytotoxic	  CD8+	  T	  cells	  (CTLs)	  express	  the	  CD8	  receptor	  that	  recognizes	  MHC	  class	  I	  molecules.	  The	  MHC	  class	  I	  molecule	  is	  ubiquitously	  expressed	  by	  cells	  to	  prevent	  CTL-­‐mediated	  destruction	  of	  normal	  cells,	  as	  they	  are	  constantly	  presenting	  self-­‐antigen	  which	  does	  not	  elicit	  an	  immune	  response.	  Aberrant	  cells	  lacking	  MHC	  class	  I	  molecules	  will	  be	  properly	  identified	  and	  eradicated	  by	  natural	  killer	  cells.	  The	  second	  subtype	  of	  T	  cells	  is	  CD4+	  T	  helper	  cells	  that	  express	  the	  CD4	  receptor.	  The	  CD4	  receptor	  recognizes	  MHC	  class	  II	  molecules	  on	  the	  surface	  of	  APCs.	  CD4+	  T	  cells	  can	  be	  further	  subdivided	  into	  different	  classes	  characterized	  by	  the	  panels	  of	  cytokines	  they	  secrete,	  which	  provide	  specific	  signals	  to	  CD8+	  T	  cells	  and	  B	  cells	  subject	  to	  a	  milieu	  of	  cytokines.	  The	  CD4+	  T	  cells	  polarize	  into	  five	  main	  types	  (TH1,	  TH2,	  TH17,	  TREG,	  and	  TFH)	  aided	  by	  the	  polarizing	  cytokines	  produced	  by	  the	  APCs	  during	  TCR	  engagement	  (Zhu	  &	  Paul,	  2010).	  The	  driving	  force	  behind	  TH	  subset	  polarization	  is	  the	  interaction	  between	  the	  pathogen	  and	  the	  pattern	  recognition	  receptors	  (PRRs)	  on	  the	  APC.	  Master	  gene	  regulators	  are	  activated	  to	  respond	  to	  different	  types	  of	  pathogens,	  resulting	  in	  the	  production	  of	  specific	  polarizing	  cytokines.	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1.2	  PKC	  
1.2.1	  PKC	  Family	  and	  Structure	  	   Upon	  activation,	  the	  Protein	  Kinase	  C	  (PKC)	  family	  specifically	  phosphorylates	  serine	  and	  threonine	  residues	  on	  target	  substrates.	  The	  PKC	  isoenzymes	  are	  classified	  into	  three	  categories	  based	  on	  their	  mechanism	  of	  activation:	  the	  conventional	  PKC	  family	  (α,	  β,	  and	  γ),	  the	  novel	  PKC	  family	  (δ,	  ε,	  η,	  and	  θ),	  and	  the	  atypical	  PKC	  family	  (λ	  and	  ς).	  Activation	  of	  conventional	  PKC	  family	  members	  requires	  calcium	  and	  diacylglycerol	  (DAG),	  whereas	  activation	  of	  novel	  PKC	  family	  members	  is	  calcium-­‐independent	  (Koivunen	  et	  al.,	  2006).	  Activation	  of	  atypical	  PKC	  family	  members	  is	  independent	  of	  calcium	  and	  of	  DAG.	  	  	   PKCθ	  has	  been	  shown	  to	  play	  a	  critical	  role	  in	  T	  cell	  activation	  and	  its	  structure	  is	  relatively	  conserved	  across	  other	  members	  of	  the	  novel	  PKC	  family.	  The	  overall	  structure	  contains	  an	  NH2	  terminus,	  C2-­‐like	  domain,	  pseudosubstrate	  (PS)	  domain,	  DAG	  binding	  domain	  (C1),	  unique	  V3	  domain	  and	  kinase	  domain,	  depicted	  in	  Figure	  1.1	  (Xu	  et	  al.,	  2004).	  In	  the	  inactive	  form	  of	  PKCθ,	  the	  PS	  domain	  remains	  bound	  to	  the	  kinase	  domain	  preventing	  PKCθ	  from	  phosphorylating	  substrates.	  	  	  
1.2.2	  PKCθ 	  Signaling	  	   In	  the	  PLC	  signaling	  pathway	  of	  T	  cells,	  PLCγ1	  breaks	  down	  phosphatidylinositol	  4,5-­‐bisphosphate	  PIP2,	  generating	  IP3	  and	  DAG.	  DAG	  induces	  a	  conformational	  change	  in	  PKCθ	  prior	  to	  binding	  PKCθ,	  creating	  the	  active	  form	  of	  PKCθ.	  Critical	  to	  PKCθ	  activation	  is	  phosphorylation	  of	  a	  tyrosine	  residue	  in	  the	  C2-­‐like	  domain	  by	  the	  kinase	  Lck,	  however	  it	  remains	  unclear	  at	  which	  stage	  this	  event	  takes	  place	  during	  PKCθ	  activation	  (Cartwright	  et	  al.,	  2011).	  Fully	  activated	  PKCθ	  bound	  to	  DAG	  is	  recruited	  to	  the	  membrane	  at	  the	  immunological	  synapse,	  where	  PKCθ	  phosphorylates	  a	  series	  of	  adaptor	  proteins	  (Carma1	  and	  TAK1	  complex).	  The	  phosphorylation	  of	  the	  scaffolding	  protein,	  Carma1,	  activates	  the	  CBM	  complex	  (Carma1,	  Bcl10,	  and	  MALT-­‐1),	  which	  then	  recruits	  TRAF6,	  an	  ubiquitin	  ligase.	  TRAF6	  ubiquitinates	  the	  IκB	  Kinase	  IKK	  complex	  (composed	  of	  NEMO,	  IKKα,	  and	  IKKβ),	  leading	  to	  the	  subsequent	  destruction	  of	  the	  NF-­‐κB	  inhibitor,	  IκB	  (Sun	  et	  al.,	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2004).	  Active	  NF-­‐κB	  translocates	  to	  the	  nucleus	  driving	  the	  transcription	  of	  the	  IL2	  gene.	  Importantly,	  PKCθ	  loss-­‐of-­‐function	  experiments	  have	  shown	  that	  T	  cell	  development	  remains	  normal,	  while	  effector	  T	  cells	  failed	  to	  produce	  normal	  responses	  (Sun	  et	  al.,	  2000).	  At	  the	  transcriptional	  level,	  IL2	  expression	  is	  impaired	  as	  a	  result	  of	  damped	  signaling	  through	  the	  NF-­‐κB,	  AP-­‐1	  and	  NFAT	  pathways	  (Hayashi	  et	  al.,	  2007).	  	  Recently,	  PKCθ	  has	  been	  shown	  to	  mediate	  T	  cell	  gene	  expression	  in	  the	  nucleus	  in	  a	  NF-­‐κB–dependent	  manner	  (Sutcliffe	  et	  al.,	  2012).	  This	  novel	  function	  of	  PKCθ	  raises	  many	  questions	  about	  the	  signaling	  events	  at	  the	  immunological	  synapse	  and	  the	  interacting	  proteins	  that	  aid	  in	  the	  translocation	  of	  PKCθ	  into	  the	  nucleus.	  
1.3.	  Notch	  
1.3.1	  Notch	  Family	  and	  Structure	  	   The	  Notch	  family	  of	  proteins	  plays	  a	  role	  in	  cell	  fate	  decisions	  across	  a	  variety	  of	  cell	  types,	  and	  is	  especially	  critical	  to	  T	  cell	  activation,	  proliferation,	  and	  differentiation.	  The	  Notch	  family	  was	  named	  after	  its	  discovery	  in	  Drosophila	  melanogaster	  in	  1914,	  after	  mutations	  in	  the	  gene	  caused	  a	  ‘notched’	  wing	  phenotype	  (Morgan	  et	  al.,	  1917).	  There	  are	  four	  paralogs	  of	  mammalian	  Notch	  proteins	  (Notch1-­‐4).	  Notch	  proteins	  belong	  to	  the	  family	  of	  type	  I	  transmembrane	  receptors	  consisting	  of	  36	  ligand	  binding	  epidermal	  growth	  factor	  (EGF)-­‐like	  tandem	  repeats	  and	  3	  LIN-­‐12/Notch	  (LIN)	  repeats	  in	  the	  extracellular	  domain.	  The	  intracellular	  domain	  contains	  an	  RBPjκ-­‐binding	  (RAM)	  domain,	  six	  tandem	  ankyrin	  (ANK)	  repeats,	  a	  transcriptional	  activation	  domain	  (TAD)	  and	  a	  proline/glutamate/serine/threonine-­‐rich	  (PEST)	  sequence,	  depicted	  in	  Figure	  1.2	  (Kopan	  et	  al.,	  2009).	  Generation	  of	  a	  fully	  mature	  Notch	  protein	  requires	  post-­‐translational	  cleavage	  of	  the	  S1	  site	  before	  forming	  a	  non-­‐covalently	  linked	  heterodimer	  through	  the	  association	  of	  two	  extracytoplasmic	  membrane	  regions	  at	  the	  N-­‐	  and	  C-­‐terminus	  of	  the	  protein.	  	  
1.3.2	  Notch	  Activation	  and	  Signaling	  	   There	  are	  two	  families	  of	  Notch	  ligands	  capable	  of	  binding	  the	  Notch	  receptor	  and	  initiating	  Notch	  signaling,	  Jagged	  (1,2)	  and	  Delta-­‐like	  (1,3,	  &	  4).	  After	  binding	  a	  Notch	  ligand,	  the	  extracellular	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domain	  of	  the	  Notch	  receptor	  is	  cleaved	  by	  TNF-­‐α-­‐converting	  enzyme	  (TACE)	  at	  S2.	  Fully	  activated,	  intracellular	  Notch	  (NotchIC)	  requires	  a	  third	  cleavage	  by	  gamma-­‐secretase	  at	  S3,	  at	  which	  point	  Notch	  translocates	  from	  the	  cell	  wall	  to	  the	  nucleus,	  depicted	  in	  Figure	  1.3	  (LaVoie	  et	  al.,	  2003).	  In	  the	  nucleus,	  NotchIC	  acts	  as	  a	  molecular	  switch,	  initiating	  gene	  transcription	  by	  converting	  the	  repressor	  CSL	  (CBF-­‐1,	  SuH,	  Lag-­‐1)	  into	  an	  activator	  (Osborne	  &	  Minter,	  2007).	  CSL	  then	  recruits	  a	  variety	  of	  co-­‐activators	  to	  change	  the	  gene	  program	  of	  the	  cell.	  CBF1/RBP-­‐J	  is	  critical	  to	  DNA-­‐binding	  in	  the	  canonical	  Notch	  signaling	  pathway.	  	   Non-­‐canonical	  Notch	  signaling	  proceeds	  independently	  of	  CSL,	  by	  activating	  the	  transcription	  factor	  NF-­‐κB	  (Perumalsamy	  et	  al.,	  2009).	  In	  the	  non-­‐canonical	  pathway,	  Notch1IC	  interacts	  with	  the	  kinase	  mammalian	  target	  of	  rapamycin	  (mTOR)	  and	  rapamycin	  independent	  companion	  of	  mTOR	  (Rictor)	  which	  results	  in	  the	  activation	  of	  the	  kinase	  Akt/PKB	  independent	  of	  CBF1/RBP-­‐J.	  	  
1.3.3	  T	  Cell	  Activation	  and	  Polarization	  	   The	  Notch1	  paralog	  plays	  an	  important	  role	  in	  T	  cell	  development,	  activation,	  and	  differentiation.	  The	  role	  of	  Notch	  signaling	  in	  T	  cell	  activation	  was	  first	  identified	  after	  stimulation	  with	  anti-­‐CD3	  and	  anti-­‐CD28	  antibodies	  resulted	  in	  increased	  levels	  of	  NotchIC.	  This	  discovery	  led	  to	  the	  identification	  of	  Notch1	  as	  an	  important	  player	  in	  T	  cell	  polarization,	  implicated	  in	  the	  development	  of	  TH1,	  TH2,	  TH17,	  and	  TREG	  cells.	  The	  production	  of	  the	  polarizing	  and	  effector	  cytokine	  for	  TH1	  cells,	  IFN-­‐γ,	  decreased	  when	  Notch	  was	  inhibited	  through	  the	  regulation	  of	  the	  transcription	  factor	  T-­‐bet.	  	  Notch	  activation	  has	  been	  implicated	  in	  polarization	  of	  multiple	  other	  families	  of	  T	  helper	  cells	  through	  a	  variety	  of	  other	  pathways,	  demonstrating	  a	  conserved	  and	  important	  role	  in	  polarization.	  	   Notch	  plays	  an	  important	  role	  in	  the	  development	  and	  activation	  of	  CD8+	  T	  cells	  by	  altering	  the	  gene	  program	  responsible	  for	  the	  expression	  of	  granzyme	  B	  and	  perforin.	  By	  inhibiting	  Notch1,	  the	  transcription	  factor	  eomesodermin	  (Eomes),	  responsible	  for	  granzyme	  B	  and	  perforin	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production	  decreased	  (Cho,	  et	  al.,	  2009).	  Further	  research	  demonstrated	  that	  the	  inhibition	  of	  Notch1	  resulted	  in	  impaired	  cytotoxic	  activity	  by	  CTLs.	  The	  decreased	  function	  of	  CTLs	  resulting	  from	  Notch1	  inhibition	  indicate	  the	  critical	  role	  Notch	  plays	  in	  the	  activation	  and	  development	  of	  a	  robust	  immune	  response	  to	  foreign	  pathogens.	  	  
1.4.	  Notch1	  and	  PKCθ	  
1.4.1	  Interaction	  	   Currently,	  information	  on	  the	  direct	  interaction	  between	  Notch1	  and	  PKCθ	  is	  limited.	  However,	  using	  microscopy	  and	  co-­‐immunoprecipitation,	  Notch1	  and	  PKCθ	  have	  been	  shown	  to	  co-­‐localize	  at	  the	  immunological	  synapse	  following	  T	  cell	  activation	  and	  both	  proteins	  physically	  interact	  with	  the	  CBM	  complex	  (Shin	  et	  al.,	  2014).	  Using	  stimulated	  Jurkat	  T	  cells,	  Shin	  et	  al.	  was	  able	  to	  demonstrate	  an	  association	  between	  PKCθ	  and	  Notch1	  by	  immunoprecipitating	  Notch1	  and	  probing	  for	  PKCθ.	  The	  interaction	  was	  believed	  to	  be	  a	  result	  of	  both	  proteins	  interacting	  with	  the	  CBM	  complex.	  	  
1.4.2	  Notch1	  and	  PKCθ 	  Regulate	  T	  cell	  Activation	  
	   One	  of	  the	  most	  critical	  transcriptional	  changes	  that	  occurs	  in	  stimulated	  T	  cells,	  is	  the	  increased	  expression	  of	  the	  IL2	  gene	  driven	  by	  the	  NF-­‐κB	  signaling	  pathway.	  It	  has	  been	  previously	  shown	  that	  Notch1	  and	  PKCθ	  play	  direct	  roles	  in	  the	  activation	  of	  NF-­‐κB.	  The	  mechanism	  by	  which	  NF-­‐κB	  is	  activated	  by	  PKCθ	  is	  well	  characterized;	  however,	  the	  function	  of	  Notch1	  in	  the	  pathway	  is	  not.	  It	  appears	  that	  Notch1	  may	  act	  as	  a	  scaffold	  protein	  that	  supports	  the	  localization	  and	  formation	  of	  the	  CBM	  complex	  that	  requires	  phosphorylation	  by	  PKCθ	  to	  induce	  complete	  activation	  of	  the	  complex	  (Figure	  1.4).	  The	  primary	  function	  of	  the	  CBM	  complex	  is	  to	  activate	  IKK	  (IκB	  kinase)	  complex	  through	  phosphorylation	  and	  ubiquitination.	  The	  active	  IKK	  complex	  phosphorylates	  the	  Inhibitor	  of	  NF-­‐κB	  (IκB)	  resulting	  in	  IκB	  becoming	  inactive.	  Inactivation	  of	  IκB	  releases	  NF-­‐κB,	  allowing	  it	  to	  translocate	  to	  the	  nucleus	  and	  initiate	  gene	  activation.	  The	  ability	  of	  Notch1	  to	  bind	  Carma1	  paralleled	  with	  PKCθ’s	  direct	  phosphorylation	  of	  the	  CBM	  complex	  suggests	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a	  synergistic	  role	  of	  PKCθ	  and	  Notch1	  in	  T	  cell	  activation.	  Studies	  have	  also	  demonstrated	  that	  both	  Notch1	  and	  PKCθ	  are	  required	  for	  the	  initial	  formation	  of	  the	  CBM	  complex	  furthering	  the	  notion	  that	  these	  proteins	  are	  critical	  to	  driving	  the	  activation	  of	  T	  cells	  mediated	  by	  NF-­‐κB.	  Additionally,	  the	  recent	  discovery	  of	  a	  nuclear	  function	  of	  PKCθ	  in	  the	  NF-­‐κB-­‐mediated	  gene	  expression	  further	  supports	  the	  notion	  of	  an	  interplay	  between	  Notch1	  and	  PKCθ,	  outside	  of	  their	  role	  in	  the	  formation	  of	  the	  CBM	  complex.	  
1.5	  Aim	  of	  the	  study	  
1.5.1	  Rationale	  	   The	  activation	  and	  polarization	  of	  T	  cells	  is	  not	  only	  a	  crucial	  aspect	  of	  providing	  protection	  against	  foreign	  pathogens,	  but	  has	  therapeutic	  implications	  across	  several	  disease	  categories	  including	  cancer	  and	  autoimmune	  disease.	  Notch1	  and	  PKCθ	  regulate	  the	  maturation	  and	  activation	  of	  CD8+	  T	  cells	  as	  well	  as	  the	  activation	  and	  polarization	  of	  CD4+	  T	  cells	  through	  the	  activation	  of	  the	  transcription	  factor	  NF-­‐κB.	  Outside	  of	  their	  unique	  functions	  in	  the	  assembly	  of	  the	  CBM	  complex,	  no	  direct	  interaction	  between	  Notch1	  and	  PKCθ	  has	  been	  demonstrated	  that	  would	  identify	  their	  relationship	  in	  time	  and	  space	  within	  T	  cells,	  which	  appears	  to	  be	  seamlessly	  intertwined	  during	  T	  cell	  activation.	  
1.5.2	  Hypothesis	  	  	   In	  this	  study,	  we	  hypothesize	  that	  a	  conserved	  domain	  on	  Notch1	  is	  responsible	  for	  interacting	  with	  PKCθ	  in	  the	  activation	  of	  T	  cells.	  
1.5.3	  Experimental	  Approach	  	   Previous	  studies	  that	  demonstrated	  Notch1	  and	  PKCθ	  interacting	  were	  performed	  in	  T	  cell	  lines	  that	  contained	  the	  proteins	  that	  make	  up	  the	  CBM	  complex.	  In	  order	  to	  demonstrate	  a	  direct	  interaction,	  without	  the	  formation	  of	  the	  CBM	  complex,	  a	  HEK	  293	  cell	  line	  was	  selected	  to	  control	  for	  a	  non-­‐direct	  interaction.	  The	  HEK	  293	  cell	  line	  does	  not	  express	  Notch1	  and	  PKCθ,	  thus	  these	  proteins	  were	  expressed	  only	  after	  successful	  transfection	  of	  plasmid	  DNA	  encoding	  Notch1	  and	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PKCθ	  plasmids.	  The	  HEK	  293	  cell	  line	  also	  has	  the	  advantage	  of	  lacking	  all	  members	  of	  the	  CBM	  complex,	  which	  may	  result	  in	  the	  indirect	  interaction	  of	  Notch	  and	  PKCθ.	  The	  Notch1IC	  construct	  contains	  an	  N-­‐terminus	  GFP	  tag	  and	  a	  C-­‐terminus	  Nuclear	  Export	  Signal	  (NES)	  (LALKLAGLDL)	  and	  Myc	  tag	  (EQKLISEEDL)	  in	  a	  pEGFP-­‐C1	  vector.	  The	  PKCθ	  construct	  was	  tagged	  on	  the	  C-­‐terminus	  with	  FLAG	  in	  a	  pCMV6-­‐Entry	  vector.	  After	  a	  direct	  interaction	  between	  Notch1	  and	  PKCθ	  is	  established,	  Notch1	  deletion	  constructs	  (Figure	  1.5)	  generated	  by	  Dr.	  Hyun	  Mu	  Shin	  will	  be	  used	  to	  identify	  the	  conserved	  region	  on	  Notch1	  responsible	  for	  binding	  PKCθ.	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Figure	  1.1:	  PKCθ	  Structure	  and	  Phosphorylation	  Sites	  	  A	  diagram	  showing	  the	  domains	  PKCθ,	  containing	  phosphorylation	  sites	  and	  the	  catalytic	  region	  responsible	  for	  PKCθ’s	  kinase	  activity.	  Lck	  phosphorylates	  a	  tyrosine	  residue	  within	  the	  C2	  domain	  upon	  T	  cell	  activation.	  The	  C1	  domain	  binds	  DAG,	  allowing	  the	  conformational	  change	  in	  PKCθ	  to	  form	  active	  PKCθ.	  (Isakov	  et	  al.	  	  J	  Clin	  Cell	  Immunol	  2012)
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2.1.	  Transfection	  Optimization	  	   HEK	  293	  cells	  were	  cultured	  at	  37OC,	  5%	  CO2	  until	  they	  were	  60-­‐80%	  confluent.	  	  Single	  transfections	  of	  plasmid	  DNA	  were	  performed	  to	  confirm	  expression	  of	  Notch1-­‐GFP	  fusion	  constructs	  and	  the	  Flag-­‐tagged	  PKCθ	  construct.	  At	  12h	  intervals,	  the	  cells	  expressing	  GFP	  were	  imaged	  using	  fluorescence	  microscopy	  to	  determine	  transfection	  efficiency	  (Figure	  2.1).	  Visual	  estimates	  indicated	  peak	  GFP	  expression	  (up	  to	  90%)	  for	  the	  transfected	  HEK	  293	  cells	  at	  48	  hours	  (Figure	  2.2).	  	  After	  the	  48h	  time	  point	  GFP	  expression	  gradually	  decreased	  due	  to	  cell	  death	  and	  cell	  division.	  	   Transfection	  both	  of	  Notch1-­‐GFP	  fusion	  constructs	  and	  the	  Flag-­‐tagged	  PKCθ	  construct	  was	  performed	  using	  a	  1:1	  ratio	  of	  plasmid	  DNA	  from	  both	  constructs.	  After	  initial	  Western	  Blots	  showed	  a	  higher	  expression	  of	  the	  Notch1	  construct	  and	  almost	  no	  expression	  of	  the	  PKCθ	  construct,	  the	  levels	  of	  plasmid	  DNA	  for	  each	  construct	  were	  optimized	  by	  changing	  the	  ratio	  of	  plasmid	  DNA	  of	  each	  construct	  as	  well	  as	  the	  amount	  of	  Xtremegene	  used	  in	  the	  transfection.	  By	  using	  a	  2:1	  ratio	  of	  the	  PKCθ	  plasmid	  to	  the	  Notch1	  plasmid,	  a	  lower	  level	  of	  GFP-­‐expression	  was	  seen	  using	  fluorescence	  microscopy	  but	  Western	  blot	  analysis	  was	  better	  able	  to	  detect	  both	  Notch1	  and	  PKCθ	  in	  the	  whole	  cell	  lysates.	  It	  was	  noted	  that	  there	  was	  increased	  cell	  death	  during	  transfection	  experiments	  in	  which	  both	  plasmid	  were	  used	  compared	  to	  single	  transfection.	  
2.2.	  Localization	  of	  Notch1	  and	  PKCθ 	  	   Isolation	  of	  nuclear	  and	  cytoplasmic	  lysates	  was	  performed	  using	  a	  commercially	  available	  kit	  (Thermo	  Scientific).	  The	  flag-­‐tagged	  PKCθ	  transfected	  into	  HEK	  293	  cells	  was	  seen	  exclusively	  in	  the	  cytoplasm	  of	  the	  cell	  shown	  in	  Figure	  2.3.	  The	  Notch1	  constructs	  were	  found	  in	  both	  the	  nucleus	  and	  the	  cytoplasm.	  Notch1IC	  localized	  to	  the	  nucleus	  which	  is	  where	  the	  naturally	  occurring	  Notch1IC	  protein	  localizes	  following	  cleavage	  from	  the	  transmembrane	  domain	  upon	  T	  cell	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activation.	  Notch1IC-­‐NES	  was	  primarily	  found	  in	  the	  cytoplasm	  as	  a	  result	  of	  the	  Nuclear	  Export	  Sequence	  tag.	  	  	  













Figure	  2.2:	  EGFP	  expression	  imaged	  using	  10x	  FITC	  filtered	  fluorescent	  microscopy	  at	  48	  
hours	  after	  transfection,	  illustrating	  robust	  EGFP	  expression	  and	  effective	  transfection	  of	  









Figure	  2.3:	  Nuclear	  and	  cytoplasmic	  fractionation	  in	  HEK	  293	  cell	  line	  show	  PKCθ	  remaining	  
in	  the	  cytoplasm,	  while	  Notch1	  localizes	  to	  the	  nucleus	  unless	  tagged	  with	  a	  Nuclear	  Export	  








Figure	  2.4:	  Co-­IP	  of	  Notch1	  and	  PKCθ 	  constructs	  in	  HEK	  293	  cell	  line	  failed	  to	  demonstrate	  a	  





DISCUSSION	  	   The	  roles	  of	  Notch1	  and	  PKCθ	  signaling	  in	  the	  development,	  activation,	  and	  polarization	  of	  the	  adaptive	  immune	  response	  are	  undoubtedly	  intertwined	  and	  synergistic	  in	  many	  T	  cell	  responses.	  Through	  the	  use	  of	  a	  HEK	  293	  cell	  line	  we	  attempted	  to	  dissect	  a	  very	  specific	  and	  direct	  interaction	  that	  is	  maintained	  independent	  of	  the	  CBM	  complex	  and	  engagement	  in	  the	  TCR.	  There	  are	  a	  multitude	  of	  reasons	  why	  the	  CO-­‐IP	  experiments	  performed	  failed	  to	  demonstrate	  a	  direct	  interaction.	  	   The	  human	  PKCθ	  construct	  that	  was	  used	  to	  transfect	  the	  HEK293	  cells	  is	  not	  phosphorylated	  at	  the	  Thr538	  residue,	  which,	  increasingly,	  appears	  to	  be	  critically	  important	  to	  proper	  PKCθ	  activity	  in	  T	  cell	  activation.	  The	  phosphorylated,	  active	  form	  of	  PKCθ	  is	  crucial	  to	  formation	  of	  the	  CBM	  complex,	  and	  suggests	  that	  the	  Notch1-­‐PKCθ	  interaction	  we	  were	  seeking	  to	  identify	  is	  dependent	  upon	  a	  conformational	  change	  in	  PKCθ	  as	  a	  result	  of	  its	  phosphorylation.	  	  	   HEK	  293	  cells	  lack	  TCRs	  and,	  thus,	  the	  immunological	  synapse	  where	  Notch1	  and	  PKCθ	  may	  co-­‐localize	  in	  T	  cells.	  In	  this	  experimental	  design,	  Notch1	  and	  PKCθ	  may	  have	  failed	  to	  interact	  simply	  because	  they	  were	  not	  recruited	  to	  a	  conserved	  physical	  location	  in	  the	  cell	  to	  form	  a	  close	  interaction.	  Several	  scaffold	  proteins	  are	  critical	  to	  formation	  of	  the	  CBM	  complex	  in	  T	  cells,	  which	  might	  be	  cause	  for	  the	  lack	  of	  interaction	  in	  the	  HEK293	  cell	  line.	  The	  Notch1	  construct	  may	  have	  been	  cycling	  in	  and	  out	  of	  the	  nucleus	  while	  PKCθ	  remained	  in	  the	  cytoplasm	  as	  the	  nuclear	  and	  cytoplasmic	  lysates	  run	  on	  a	  western	  blot	  suggest.	  	  	   The	  issue	  with	  the	  two-­‐plasmid	  transfection	  is	  also	  a	  potential	  problem	  that	  resulted	  in	  the	  failure	  to	  show	  a	  direct	  interaction	  between	  PKCθ	  and	  Notch1.	  Both	  plasmids	  use	  the	  CMV	  promoter	  that	  was	  effective	  in	  single	  plasmid	  transfections;	  however,	  it	  is	  a	  very	  strong	  promoter	  so	  the	  cell	  may	  become	  exhausted	  and	  die	  when	  both	  proteins	  begin	  to	  be	  synthesized	  inside	  the	  cell.	  Our	  possibility	  is	  that	  the	  cells	  successfully	  transfected	  with	  both	  plasmids	  quickly	  died	  before	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MATERIALS	  AND	  METHODS	  
5.1.	  Cell	  Culture	  Human	  Embryonic	  Kidney	  (HEK)	  293	  cells	  were	  cultured	  in	  RPMI	  1640	  with	  1%	  L-­‐glutamate,	  0.5%	  Na	  pyruvate,	  1%	  penicillin-­‐streptomycin	  and	  10%	  FBS.	  The	  HEK	  293	  cells	  were	  incubated	  at	  37OC,	  5%	  CO2.	  
5.2.	  Plasmid	  DNA	  All	  Notch	  plasmids	  were	  generated	  by	  Hyun	  Mu	  Shin.	  The	  human	  PKCθ	  plasmid	  was	  purchased	  from	  OriGene	  (PRKCQ	  Human	  cDNA	  ORF	  Clone).	  
5.3.	  Competent	  Cells	  XL1	  Blue	  Escherichia	  coli	  cells	  were	  grown	  overnight	  in	  50	  mL	  of	  fresh	  LB	  media	  in	  a	  200	  mL	  conical	  flask	  to	  an	  OD600	  of	  0.2-­‐.0.5.	  The	  culture	  was	  pelleted	  and	  resuspended	  in	  5mL	  of	  chilled	  TSS	  buffer	  (10%	  PEG	  8000,	  20mM	  MgCl2,	  5%	  DMSO,	  and	  LB	  media:	  filter	  sterilized).	  100	  µL	  aliquots	  were	  added	  to	  chilled	  Eppendorf	  tubes	  and	  stored	  at	  -­‐80OC	  for	  bacterial	  transformation.	  
5.4.	  Bacterial	  Transformation	  Competent	  XL1	  Blue	  cells	  were	  removed	  from	  -­‐80OC	  and	  thawed	  on	  ice.	  100	  ng	  of	  plasmid	  DNA	  was	  added	  to	  2	  mL	  Eppendorf	  tubes	  containing	  100	  µL	  of	  XL1	  blue	  cells	  and	  incubated	  on	  ice	  for	  20-­‐30	  minutes.	  The	  competent	  cell/DNA	  mixture	  was	  heat	  shocked	  in	  a	  42OC	  water	  bath	  for	  45	  seconds,	  and	  then	  incubated	  on	  ice	  for	  2	  minutes.	  500	  µL	  of	  LB	  media	  was	  added	  to	  the	  competent	  cell/DNA	  mixture.	  The	  Eppendorf	  tube	  was	  placed	  in	  a	  37OC	  shaking	  incubator	  for	  45	  minutes.	  200	  µL	  of	  the	  mixture	  was	  plated	  onto	  a	  10	  cm	  LB	  agar	  plate	  containing	  50	  µg/mL	  kanamycin	  and	  incubated	  at	  37OC	  overnight.	  	  
5.5.	  Mini-­prep	  and	  Maxi-­prep	  All	  mini-­‐preps	  were	  performed	  using	  QIAprep	  Spin	  Mini-­‐prep	  Kit	  according	  to	  the	  manufacturer’s	  specifications	  (Qiagen).	  All	  maxipreps	  were	  performed	  using	  Biotool’s	  Maxi-­‐prep	  Kit	  according	  to	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the	  manufacturer’s	  specifications	  (Biotool).	  All	  DNA	  concentrations	  were	  measured	  using	  Biodrop	  according	  to	  manufacturer’s	  specifications	  (Biodrop).	  	  
5.6.	  Sequencing	  and	  Sequence	  Analysis	  All	  sequencing	  of	  plasmid	  DNA	  was	  done	  by	  Genewiz	  using	  the	  primers	  outlined	  in	  Table	  1.	  Analysis	  of	  the	  sequences	  was	  performed	  using	  the	  UGENE	  analysis	  software.	  	  
5.7.	  Transfection	  HEK	  293	  Cells	  were	  transfected	  using	  Xtremegene	  according	  the	  manufacturers’	  specifications.	  Cells	  were	  grown	  in	  10	  cm	  cell	  culture	  plates	  until	  they	  were	  65-­‐80%	  confluent.	  10	  µg	  of	  plasmid	  DNA	  and	  10	  µL	  of	  Xtremegene	  were	  added	  to	  1	  mL	  of	  serum-­‐free	  media	  and	  incubated	  for	  30	  minutes	  before	  being	  added	  drop	  wise	  to	  the	  HEK	  293	  cell	  culture.	  Cells	  were	  harvested	  48	  hours	  post	  transfection.	  Transfection	  efficiency	  was	  monitored	  using	  fluorescence	  microscopy.	  
5.8.	  Protein	  Extraction	  Whole	  cell	  lysates	  were	  collected	  using	  Lysis	  buffer	  (50	  mM	  Hepes	  pH	  7.8,	  250	  mM	  NaCl,	  1%	  Nonidet	  P-­‐40,	  2	  mM	  EDTA	  and	  protease	  inhibitors).	  Nuclear	  and	  cytoplasmic	  lysates	  were	  collected	  using	  NE-­‐PER	  Nuclear	  and	  Cytoplasmic	  Extraction	  Reagents	  (Thermo	  Scientific)	  according	  to	  manufacturer’s	  specifications.	  Protein	  concentrations	  were	  measured	  using	  a	  BCA	  Assay	  according	  to	  manufacturer’s	  specifications	  (Thermo	  Scientific).	  	  
5.9.	  Western	  Blot	  and	  Co-­Immunoprecipitation	  Western	  blots	  were	  performed	  by	  adding	  20-­‐50	  µg	  of	  protein	  to	  a	  10%	  SDS-­‐polyacrylamide	  gel	  and	  separated	  using	  electrophoresis.	  The	  protein	  was	  transferred	  onto	  polyvinylidenedifluoride	  (PVDF)	  membranes	  using	  a	  wet	  transfer	  (Millipore).	  The	  membranes	  were	  probed	  using	  antibodies	  outlined	  in	  Table	  2.	  Horseradish	  peroxidase-­‐conjugated	  secondary	  antibodies	  were	  used	  in	  western	  blot	  experiments.	  Protein	  bands	  were	  detected	  with	  enhanced	  chemiluminescence	  (ECL,	  Thermo	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Scientific).	  Membranes	  were	  blocked	  using	  either	  PBS	  or	  TBS	  with	  0.1%	  Tween-­‐20	  and	  3-­‐5%	  dry	  fat-­‐free	  milk	  powder.	  Following	  protein	  quantification	  using	  a	  BCA	  assay,	  1	  mg	  of	  whole	  cell	  lysate	  was	  incubated	  with	  5-­‐10	  µg/mL	  of	  primary	  antibody	  for	  2-­‐10	  hours,	  4OC.	  After	  washing	  lysates/antibody	  mixture,	  the	  supernatant	  was	  transferred	  to	  an	  Eppendorf	  tube	  containing	  60µL	  of	  protein	  A/G	  sepharose	  beads.	  The	  beads	  and	  supernatant	  was	  place	  on	  a	  wheel	  at	  4OC.	  Laemmli	  sample	  buffer	  was	  added	  and	  the	  tubes	  were	  spun	  down	  after	  a	  5-­‐minute	  incubation	  at	  95OC	  to	  disassociate	  the	  bead/antibody	  interaction.	  The	  supernatant	  was	  collected	  containing	  only	  the	  proteins	  that	  bound	  to	  the	  sepharose	  beads.	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Table	  1:	  Antibodies	  
	  
Antigen	   Species	   Source	  Notch1	   Rabbit	   Santa	  Cruz	  PKCθ	   Rabbit	   Sigma	  GFP	   Rabbit	   Sigma	  Flag	   Mouse	   Santa	  Cruz	  
β-­‐Actin	   Mouse	   Sigma	  HDAC1	   Rabbit	   Cell	  Signaling	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